XTalks

MARCH 15, 2024

LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. Physicians can send prescriptions for their patients either to LillyDirect Pharmacy Solutions or Amazon Pharmacy.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

XTalks

MAY 24, 2023

According to the company, it is an attempt to focus on its core businesses which include retail pharmacy, health insurance, prescription drug coverage and health care and wellness. CVS is known for its retail pharmacies, and perhaps the clinical trials unit was not a strategic fit for the company.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharmacy 97

Drug Discovery World

OCTOBER 5, 2022

The company hopes that through its technology, academics, life science industries and pharma industries can test and develop more personalised treatments for intricate tissue engineering and cell therapy, such as repairing damaged tissue, replacing lost biological functions, localised therapeutic solutions and complex drug formulations. .

Drugs 52

Drugs Regulation Manufacturing Medicine 52

XTalks

AUGUST 30, 2022

One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

JANUARY 31, 2023

As Amazon continues to ramp up its healthcare portfolio, the online behemoth rolled out RxPass last week, a flat fee drug program through which customers can buy an unlimited amount of commonly prescribed generic medications for $5 a month. It also purchased primary care company One Medical in a mammoth $3.9 billion deal in July.

Pharmacy 52

Pharmacy Drugs Branding Generic Drugs 52

XTalks

JULY 28, 2020

Now, results from a new study conducted by researchers at the UC San Francisco (UCSF) School of Pharmacy and the Novartis Institutes for BioMedical Research (NIBR), have challenged drugmakers’ understanding of the effects of excipients.

Protein 103

Protein Drugs In-Vitro Scientist 103